Jagsonpal Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Buyback is 04-May-2026.

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.4%1-day move

₹203.65

prior close

₹201.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.9+0.9+0.6+0.6+2.4+2.3+5.6+3.1+3.1+6.7-2.2+1.2+13.0—

Up moveDown movePending

AI summary

Jagsonpal Pharmaceuticals has fixed Monday, May 4, 2026, as the record date for its proposed buyback of up to 16 lakh fully paid-up equity shares. The buyback will be carried out at a price of ₹250 per share, with the total outlay not exceeding ₹40 crores. Shareholders holding shares as of the record date will be eligible to participate in the buyback. The decision was taken by the buyback committee at its meeting held on April 27, 2026.

Likely market impact

The buyback at ₹250 per share is significantly above the face value of ₹2, making it potentially attractive for eligible shareholders. Typically, buybacks signal management's confidence in the company's valuation and can support the stock price in the short term, though the actual premium over market price will determine the real impact.